Broad Institute provided COVID-19 screening for students, faculty and staff at more than 100 colleges and universities
On Sept. 2, 2020, Broad Institute of MIT and Harvard announced it had partnered with 108 public and…
Novavax announced publication of phase 1 data for COVID-19 vaccine candidate in The New England Journal of Medicine
On Sept. 2, 2020, Novavax announced the publication in The New England Journal of Medicine of Phase 1…
OPKO Health’s BioReference Laboratories announced New York City Schools COVID-19 testing program
On Sept. 2, 2020, BioReference Laboratories, an OPKO Health company, began testing New York City principals, teachers and…
Aegis Sciences awarded $66 million NIH grant to rapidly expand COVID-19 test capacity
On Sept. 2, 2020, Aegis Sciences annunced that it had been selected to participate in the National Institutes…
Biotechnology | COVID-19 | NIH
PathGroup selected by NIH to become RADx program ‘mega-lab’ for COVID-19 testing
On Sept. 2, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…
Sonic Healthcare expand COVID-19 testing capacity in US in collaboration with NIH RADx Initiative
On Sept. 2, 2020, Sonic Healthcare USA was awarded a contract from the National Institutes of Health (NIH)…
Ceres received $65M NIH award to expand Nanotrapﾮ particle manufacturing capacity for COVID-19 testing
On Sept. 2, 2020, Ceres Nanosciences announced it had been awarded a contract from the National Institutes of…
NIH awarded MicroGEM $409 million to fast-track rapid, no-lab COVID-19 saliva test
On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…
NIH to boost national COVID-19 testing capacity
On Sept. 2, 2020, the NIH announced $129.3 million in scale-up and manufacturing support for a new set…
National Wastewater Surveillance System launched to detect antimicrobial resistance and COVID-19
In September 2020, the Centers for Disease Control and Prevention (CDC) announced the launch of the National Wastewater…
Titers of antibodies against SARS-CoV2 did not decline within four months
On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…
MediciNova announced development progress on intranasal formulation of SARS-CoV-2 vaccine for COVID-19
On Sept. 1, 2020, MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a…
COVID-19 | Disease | FDA | Therapeutics
City of Hope doctors lead novel clinical trial to treat cancer patients with COVID-19
On Sept. 1, 2020, City of Hope announced that it was investigating an innovative treatment for cancer patients…
Sanofi updated Kevzara (sarilumab) phase 3 trial in severe and critically ill COVID-19 patients outside the US
On Sept. 1, 2020, Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara (sarilumab) at…
HDT BIO received NIH contract to advance novel RNA/LIONﾙ COVID-19 vaccine into clinical trials
On Sept. 1, 2020, HDT Bio received a notice of award from the National Institute of Allergy and…
Phase 3 clinical testing in the US of AstraZeneca COVID-19 vaccine candidate began
On Aug. 31, 2020, a multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222…
Development of COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial across all adult age groups
On Aug. 31, 2020, AstraZeneca announced that the COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial…
Vir Biotechnology and GSK started phase 2/3 study of COVID-19 antibody treatment
On Aug. 31, 2020, Vir Biotechnology and GlaxoSmithKline announced that the first patient was dosed in a phase…
T2 Biosystems received FDA Emergency Use Authorization for COVID-19 molecular diagnostic test
On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…
Novavax and Canada reached agreement to acquire Novavax COVID-19 vaccine
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
Todos Medical announced $23,760,000 contract for COVID-19 PCR testing equipment & supplies with Wisconsin-based laboratory
On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…
Gileadﾒs investigational antiviral Vekluryﾮ (remdesivir) received FDA Emergency Use Authorization for treatment of patients with moderate COVID-19
On Aug. 28, 2020, Gilead Sciences announced the FDA expanded the Emergency Use Authorization (EUA) enabling use of…
Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeutic
On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
FDA expanded Emergency Use Authorization for Veklury (remdesivir) to include all hospitalized patients for treatment of COVID-19
On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
The US Dept of Veterans Affairs anounced new clinical trial for Veterans with COVID-19
On Aug. 28, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a new clinical trial to study…
Vaccitech received government grant for COVID-19 vaccine research
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
Biotechnology | COVID-19 | Diagnostics | NIH
White House announced plan to deploy 150 million rapid tests in 2020
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
Laurent Pharmaceuticals received FDA approval to initiate its COVID-19 phase 2 clinical trial in the U.S.
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model
On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…